Pfizer.Inc is one of the biggest pharmaceutical and biotechnology corporations in the US. The company develops and produces medicines and vaccines, and it has multiple blockbuster drugs and other products, each of which generates over $1 billion in annual revenues.
Around 50% of the firm’s profits are coming from the United States, 8% from China and Japan, while the rest comes from other countries. In this guide, we discuss how to invest in Pfizer stock.
In This Guide
If you only wish for us to provide quick instructions on how to invest in cannabis stocks, then we show you how to do so in the steps below.
If you wish to invest in Pfizer stocks, you will first need to find a stock broker. Therefore, we have reviewed some of the popular brokers in the sections below.
eToro is one of the most popular platforms with over 26 million users.
The platform is regulated by some of the most reliable and trustworthy regulatory bodies in the entire world, including the FCA, CySEC, ASIC, and FINRA. eToro offers over 2,500 investment instruments such as ETFs, shares (e.g. Apple), crypto, etc.
Furthermore, you can invest in any of them with zero commission, and only have to pay spreads, which are also quite low. eToro has a low minimum deposit of $10, which makes it available and usable to pretty much everyone who wishes to trade.
Copy-trading is a feature of social trading, and it allows users to find a trader that deals in the same asset that they are interested in, and then copy their moves. Provided that you have found a true expert, you can mirror their moves in real-time.
Sponsored Ad. 67% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.
Users may want to research and learn more about a company before making an investment decision. Therefore, we will be discussing some basics of the Pfizer stock along with the historical price of Pfizer, in the sections below.
Pfizer is a US-based pharmaceutical and biotechnological corporation that operates around the world. It has been around for over 170 years now, and it is quite reputable. It is known for creating medicines and vaccines for immunology, cardiology, neurology, oncology, and endocrinology.
These days, however, most people know the company for its COVID-19 vaccine, which has been distributed and used around the world in order to save the lives of all those willing to protect themselves from the virus that has been plaguing the world for over a year and a half at this point.
Speaking of Pfizer’s stock price, it currently (October 29th, 2021) sits at $43.18 per share, after growing by 0.49% in the last 24 hours. The company’s stock saw a significant price drop between January 2020 and March 2020, sinking from $38.38 to $27.48. However, following the rise of the COVID-19 pandemic and the firm’s work on the vaccine, the market price has not only recovered to previous heights but even surged to a new all-time high.
The last time that Pfizer even came close to these levels was in March of 1999 and then again in June 2000. The company was then spiraling down for 9 years, hitting its bottom in February 2009. After that, it has been growing steadily for over a decade, only to once again skyrocket in 2021 and hit the mentioned ATH of $50.42 per share on August 17th of this year.
Pfizer reported that 2020 was a year like no other in the company’s entire history. It was defined by bold decisions, and even bolder actions and the firm was pleased to report achieving some incredible results. This was a year when it separated from Upjohn, which did make it 20% smaller, but it was more focused on delivering the top products for its patients.
While the company takes pride when it comes to its vaccine, it noted that this is far from the only thing that it has worked on in 2020. Of course, the vaccine itself is a result of its collaboration with BioNTech, so Pfizer had researchers and resources to dedicate to other pursuits, as well.
From a financial standpoint, the year has been challenging for everyone, and the entire business environment has suffered greatly. Even so, the company noted that it was successful in generating 8% operational revenue growth from its biopharmaceutical product portfolio, and that is excluding the results of the divested Upjohn business, as well as the revenue impact from Consumer Healthcare, and $154 million of sales of the Pfizer-BioNTech COVID-19 vaccine.
A lot of investors tend to go after dividend stocks when investing in order to secure some passive income that will allow their money to make more money. This can then be used for further investments or some other purpose.
While biotech companies typically do not have dividend yields as they simply do not see that big of a cash flow, Pfizer actually does have quarterly dividends for its stockholders, which equate to an annualized dividend rate of $1.56 per share.
Institutional investors may be interested in a company’s ESG (Environmental, Social, Governance), which is known to have a large impact on the stock price. Pfizer has consistently supported and prioritized its ESG-related commitments and programs according to the company’s CEO and Chairman, Dr Albert Bourla.
Pfizer’s COVID vaccine came in partnership with BioNTech, which the two companies entered back in 2020. Under the healthcare threat of COVID-19, the firms decided to join forces and work on creating a vaccine together, even though these days, the vaccine is known only as “the Pfizer vaccine,” and the other company name was left out.
Together, the two companies managed to develop a vaccine that offers a 95% efficiency in preventing coronavirus, and protection was successfully confirmed at least 7 days after the patient receives the second dose.
Another important thing to note is that this is the first mRNA vaccine that was ever authorised in the UK. Only days after the UK gave it green light, the US did the same, followed by Canada, and then Switzerland, as well as other countries. Before long, the so-called Pfizer vaccine traveled around the world, being implemented in treatments all over the globe, alongside the other ones.
Its official name is BNT162b2, it requires 2 shots that are 21 days apart, and it is recommended that moderately to severely immunocompromised patients receive the 3rd dose as well, at least 28 days after receiving the second one. Other people are recommended to receive the third dose as well, although only after six months passes from their 2nd shot.
Now that you know everything you need to know about Pfizer stock, you can analyse the information and make a decision on whether or not you wish to invest in the stock.
Should you choose to do so, you may want to pick a suitable brokerage that will cater to your investing needs. In the sections below, we will show you how to begin trading with the chosen broker of your choice.
Head over to the homepage of your chosen broker and begin the account set-up process. You will be required to fill in your personal details – including your full name, email address and mobile number. Create a username and password for the platform to continue.
Most popular brokers are regulated – which is why users may be required to verify their accounts. To do this, simply upload proof of ID (a copy of your driver’s license or passport) and proof of address (a copy of a bank statement or utility bill). Once these documents have been uploaded, your broker should verify them in a couple of minutes.
The next step is to deposit funds into your trading account. Most brokers may support 1 or more of the following payment methods:
Choose your preferred payment option and deposit the funds into your account.
Once your account has been funded, proceed to search for Pfizer stock by searching on your platform’s search bar. Fill in the amount you want to credit into the trade, and confirm your transaction.
Pfizer stock has seen a solid price performance over the last several months, and the company has been performing well for over a decade now. In this guide we have analysed and reviewed some key details of Pfizer stock and the company. Users should conduct their own analysis and decide whether or not to invest in Pfizer stock.
Pfizer is a multinational pharmaceutical and biotechnology corporation from the United States of America.
As a publicly-traded company, Pfizer is owned by its shareholders, the largest of which are mutual funds.
Pfizer is an American pharmaceutical and biotech company headquartered in New York City.
At the time of writing (October 29th, 2021) Pfizer’s stock price is $43.18 per share.
Ali is an experienced writer covering the cryptocurrency markets and the blockchain industry. He has 8 years of experience writing about cryptocurrencies, technology, and trading. His work can be found in various high-profiled investment sites including CCN, Capital.com, BeInCrypto, Bitcoinist, and NewsBTC.
Best UK Stock, Forex, CFD, Crypto, Social or Day Trading Platform that meets your needs.